We offer Illumina microarray processing and expertise accessible to both internal and external researchers. If you would like to discuss your assays or enquire about costs and scheduling, please ...

The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...

Kevin Gunderson and colleagues at Illumina in San Diego recently developed a whole-genome genotyping assay that bypasses PCR's multiplexing issues, using a single-tube amplification reaction combined ...

Illumina, Inc. engages in the development ... Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting.

The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Patrick B Donnelly, an analyst from Citi, maintained the Hold rating on Illumina (ILMN – Research Report). The associated price target remains ...

Besides Wall Street's top -and-bottom-line estimates for Illumina (ILMN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the ...